UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

British journal of dermatology (1951), 2015-10, Vol.173 (4), p.949-961

2015

Volltextzugriff (PDF)

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

British journal of dermatology (1951), 2012-09, Vol.167 (3), p.668-677

2012

Volltextzugriff (PDF)

Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial

British journal of dermatology (1951), 2015-05, Vol.172 (5), p.1395-1406

2015

Volltextzugriff (PDF)

Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

British journal of dermatology (1951), 2013-11, Vol.169 (5), p.992-999

2013

Volltextzugriff (PDF)

Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials

British journal of dermatology (1951), 2019-01, Vol.180 (1), p.67-75

2019

Volltextzugriff (PDF)

Quantitative Evaluations of Time‐Course and Treatment Effects of Systemic Agents for Psoriasis: A Model‐Based Meta‐Analysis

Clinical pharmacology and therapeutics, 2017-12, Vol.102 (6), p.1006-1016

2017

Volltextzugriff (PDF)

Association between serum interleukin‐17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis

Clinical and experimental dermatology, 2018-10, Vol.43 (7), p.790-797

2018

Volltextzugriff (PDF)

Obesity-related cardiovascular disease: implications of obstructive sleep apnea

Diabetes, obesity & metabolism, 2006-05, Vol.8 (3), p.250-260

2006

Volltextzugriff (PDF)

Tofacitinib benefit‐risk profile in chronic plaque psoriasis

British journal of dermatology (1951), 2019-01, Vol.180 (1), p.e19-e19

2019

Volltextzugriff (PDF)

托法替布在慢性斑块型银屑病中的获益风险特征

British journal of dermatology (1951), 2019-01, Vol.180 (1), p.e32-e32

2019

Volltextzugriff (PDF)

THU0299 An integrated analysis of changes in lipid levels and incidence of cardiovascular events following tofacitinib treatment in patients with psoriatic arthritis across phase 3 and long-term extension studies

Annals of the rheumatic diseases, 2018-06, Vol.77 (Suppl 2), p.368

2018

Volltextzugriff (PDF)

Association between plasma adiponectin levels and unstable coronary syndromes

European heart journal, 2007-02, Vol.28 (3), p.292-298

2007

Volltextzugriff (PDF)

Arrhythmogenic mechanisms in left ventricular hypertrophy

Europace (London, England), 2000-07, Vol.2 (3), p.216-223

Wolk, R

2000

Volltextzugriff (PDF)

THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials

Annals of the rheumatic diseases, 2016-06, Vol.75 (Suppl 2), p.253-253

2016

Volltextzugriff (PDF)

Leptin receptor and functional effects of leptin in human endothelial progenitor cells

Atherosclerosis, 2005-11, Vol.183 (1), p.131-139

2005

Volltextzugriff (PDF)

Extrasystolic beats affect transmural electrical dispersion during programmed electrical stimulation

European journal of clinical investigation, 2001-04, Vol.31 (4), p.293-301

2001

Volltextzugriff (PDF)

Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight

CPT: pharmacometrics and systems pharmacology, 2017-05, Vol.6 (5), p.322-330

2017

Volltextzugriff (PDF)

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Journal of the American Academy of Dermatology, 2016-05, Vol.74 (5), p.841-850

2016

Volltextzugriff (PDF)

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a New Cholesteryl Ester Transfer Protein Inhibitor in Healthy Human Subjects

Clinical pharmacology and therapeutics, 2009-10, Vol.86 (4), p.430-437

2009

Volltextzugriff (PDF)

066 Incidence rates and prevalence of hospital-treated alopecia areata in Denmark (1995-2016)

Journal of investigative dermatology, 2022-12, Vol.142 (12), p.S191-S191

2022

Volltextzugriff (PDF)

Pupillary Pain Index Changes After a Standardized Bolus of Alfentanil Under Sevoflurane Anesthesia: First Evaluation of a New Pupillometric Index to Assess the Level of Analgesia During General Anesthesia

Anesthesia and analgesia, 2019-03, Vol.128 (3), p.467-474

2019

Volltextzugriff (PDF)

598 Response to ritlecitinib treatment based on salt improvement scores in patients with alopecia areata (AA): Post hoc analysis of the allegro phase 2b/3 study

Journal of investigative dermatology, 2023-05, Vol.143 (5), p.S102-S102

2023

Volltextzugriff (PDF)

EPH57 Epidemiology of Alopecia Areata Across Global Regions – A Systematic Literature Review

Value in health, 2022-12, Vol.25 (12), p.S202-S202

2022

Volltextzugriff (PDF)

Dose Response and Pharmacokinetics of Tofacitinib (CP‐690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis

CPT: pharmacometrics and systems pharmacology, 2013-05, Vol.2 (5), p.1-8

2013

Volltextzugriff (PDF)

Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy

Pharmacology & therapeutics (Oxford), 1999-11, Vol.84 (2), p.207-231

1999

Volltextzugriff (PDF)

1 – 25 von 1.524

Suche als RSS-Feed

Aktive Filter

SpracheNorwegisch

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.346)
Mit Volltextzugriff
(1.340)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(912)
Life Sciences & Biomedicine
(729)
Humans
(687)
Female
(403)
Medicin Och Hälsovetenskap
(344)
Male
(339)
Middle Aged
(290)
Aged
(262)
Biological And Medical Sciences
(250)
Adult
(215)
Risk Factors
(212)
Medical Sciences
(193)
Oncology
(137)
Physical Sciences
(135)
Neurosciences & Neurology
(110)
Prospective Studies
(104)
Cardiovascular System & Cardiology
(101)
Aged, 80 And Over
(91)
Cohort Studies
(90)
Cardiac & Cardiovascular Systems
(87)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

EZB-FREE-00999 freely available EZB journals
(750)
MEDLINE
(743)
Ingenta Connect
(705)
Journals@Ovid
(659)
Access via ScienceDirect (Elsevier)
(390)
Single Journals
(340)
Access via Wiley Online Library
(315)
IngentaConnect Journals
(169)
Wiley Online Library Full Collection 2018
(132)
Access via Oxford University Press
(129)
SpringerNature Journals
(124)
EZB-NALI5-00465 Elsevier Archive NL
(117)
Oxford Journals 2020 Medicine
(95)
Nature
(93)
eBooks on EBSCOhost
(78)
Ebook Central Perpetual and DDA
(76)
Wiley Online Library All Obooks
(67)
Nexis Uni
(59)
EZB-NALI2-00462 Springer Archive NL
(58)
JSTOR Archive Collection A-Z Listing
(53)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

Tofacitinib withdrawal and retreatment in moderate-to-severe chronic plaque psoriasis: a randomized controlled trial

Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

Benefit–risk profile of tofacitinib in patients with moderate‐to‐severe chronic plaque psoriasis: pooled analysis across six clinical trials

Quantitative Evaluations of Time‐Course and Treatment Effects of Systemic Agents for Psoriasis: A Model‐Based Meta‐Analysis

Association between serum interleukin‐17A and clinical response to tofacitinib and etanercept in moderate to severe psoriasis

Obesity-related cardiovascular disease: implications of obstructive sleep apnea

Tofacitinib benefit‐risk profile in chronic plaque psoriasis

托法替布在慢性斑块型银屑病中的获益风险特征

THU0299 An integrated analysis of changes in lipid levels and incidence of cardiovascular events following tofacitinib treatment in patients with psoriatic arthritis across phase 3 and long-term extension studies

Association between plasma adiponectin levels and unstable coronary syndromes

Arrhythmogenic mechanisms in left ventricular hypertrophy

THU0187 Safety of Tofacitinib, An Oral Janus Kinase Inhibitor: Integrated Data Analysis from The Global Chronic Plaque Psoriasis Clinical Trials

Leptin receptor and functional effects of leptin in human endothelial progenitor cells

Extrasystolic beats affect transmural electrical dispersion during programmed electrical stimulation

Evaluating Dosage Optimality for Tofacitinib, an Oral Janus Kinase Inhibitor, in Plaque Psoriasis, and the Influence of Body Weight

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study

Pharmacokinetic, Pharmacodynamic, and Safety Profile of a New Cholesteryl Ester Transfer Protein Inhibitor in Healthy Human Subjects

066 Incidence rates and prevalence of hospital-treated alopecia areata in Denmark (1995-2016)

Pupillary Pain Index Changes After a Standardized Bolus of Alfentanil Under Sevoflurane Anesthesia: First Evaluation of a New Pupillometric Index to Assess the Level of Analgesia During General Anesthesia

598 Response to ritlecitinib treatment based on salt improvement scores in patients with alopecia areata (AA): Post hoc analysis of the allegro phase 2b/3 study

EPH57 Epidemiology of Alopecia Areata Across Global Regions – A Systematic Literature Review

Dose Response and Pharmacokinetics of Tofacitinib (CP‐690,550), an Oral Janus Kinase Inhibitor, in the Treatment of Chronic Plaque Psoriasis

Functional, structural, and dynamic basis of electrical heterogeneity in healthy and diseased cardiac muscle: implications for arrhythmogenesis and anti-arrhythmic drug therapy

Aktive Filter

Suchergebnisse filtern